News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mackaness James H
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
4
| Mackaness James H (CFO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 29,084 shares
@ $0
Granted 87,251 options to buy
@ $5.25, valued at
$458.1k
|
|
| 05/10/2023 |
4
| Mackaness James H (CFO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 2,143 warrants
@ $1.75, valued at
$3.8k
Granted 3,500 warrants
@ $2.5, valued at
$8.8k
|
|
| 01/27/2023 |
4
| Mackaness James H (CFO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $2.41, valued at
$72.3k
|
|
| 10/14/2022 |
4
| Mackaness James H (CFO) has filed a Form 4 on SOLENO THERAPEUTICS INC |
| 07/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Mackaness James H (CFO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 40,000 shares
@ $0
Bought 40,000 warrants
@ $0.3, valued at
$12k
|
|
| 02/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| Mackaness James H (CFO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 300,000 options to buy
@ $2.05, valued at
$615k
|
|
| 01/24/2020 |
4
| Mackaness James H (CFO) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 10,000 shares
@ $3.35, valued at
$33.5k
|
|
| 11/20/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/23/2018 |
4
| Mackaness James H (CFO) has filed a Form 4 on Invuity, Inc.|
Txns:
| Disposed/sold 9,599 shares
@ $0
Disposed/sold 34,800 shares
@ $0
Disposed/sold 40,000 options to buy
@ $6.5, valued at
$260k
Disposed/sold 60,900 options to buy
@ $4.1, valued at
$249.7k
Disposed/sold 9,000 restricted stock units
@ $0 |
|
| 03/19/2018 |
4
| Mackaness James H (CFO) has filed a Form 4 on Invuity, Inc.|
Txns:
| Bought 2,528 shares
@ $3.8954, valued at
$9.8k
|
|
| 02/20/2018 |
4
| Mackaness James H (CFO) has filed a Form 4 on Invuity, Inc.|
Txns:
| Paid exercise price by delivering 1,316 shares
@ $4.1, valued at
$5.4k
Granted 34,800 shares
@ $0
Exercised 3,000 restricted stock units
@ $0
Granted 60,900 options to buy
@ $4.1, valued at
$249.7k
|
|
| 02/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/09/2016 |
4
| Mackaness James H (CFO) has filed a Form 4 on Invuity, Inc. |
| 05/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2016 |
4
| Mackaness James H (CFO) has filed a Form 4 on Invuity, Inc.|
Txns:
| Granted 32,000 options to buy
@ $7.45, valued at
$238.4k
Granted 15,000 restricted stock units
@ $0 |
|
| 12/03/2013 |
4
| Mackaness James H (CFO and COO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Sold 10,000 shares
@ $10.5218, valued at
$105.2k
Exercised 10,000 options to buy
@ $2.49, valued at
$24.9k
|
|
| 11/08/2013 |
4
| Mackaness James H (CFO and COO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Sold 10,000 shares
@ $8.3496, valued at
$83.5k
Exercised 10,000 options to buy
@ $2.49, valued at
$24.9k
|
|
| 06/20/2013 |
4
| Mackaness James H (CFO and COO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Sold 4,358 shares
@ $5.4053, valued at
$23.6k
Sold 7,888 shares
@ $5.4029, valued at
$42.6k
Sold 3,958 shares
@ $5.408, valued at
$21.4k
Sold 3,658 shares
@ $0.9, valued at
$3.3k
Exercised 4,358 options to buy
@ $2.49, valued at
$10.9k
Exercised 7,888 options to buy
@ $2.49, valued at
$19.6k
Exercised 3,958 options to buy
@ $2.49, valued at
$9.9k
Exercised 3,658 options to buy
@ $0.9, valued at
$3.3k
|
|
| 06/18/2013 |
4
| Mackaness James H (CFO and COO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Sold 1,057 shares
@ $5.4001, valued at
$5.7k
Sold 6,114 shares
@ $5.3739, valued at
$32.9k
Sold 3,057 shares
@ $5.3739, valued at
$16.4k
Sold 255 shares
@ $5.5, valued at
$1.4k
Exercised 85 shares
@ $0.9, valued at
$76.5
Sold 85 shares
@ $5.5, valued at
$467.5
Exercised 1,057 options to buy
@ $2.49, valued at
$2.6k
Exercised 6,114 options to buy
@ $2.49, valued at
$15.2k
Exercised 3,057 options to buy
@ $0.9, valued at
$2.8k
Exercised 255 options to buy
@ $2.49, valued at
$635
Exercised 85 options to buy
@ $5.38, valued at
$457.3 |
|
| 06/12/2013 |
4
| Mackaness James H (CFO and COO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Sold 2,100 shares
@ $5.3358, valued at
$11.2k
Sold 1,500 shares
@ $5.4307, valued at
$8.1k
Sold 570 shares
@ $5.3983, valued at
$3.1k
Sold 2,800 shares
@ $5.3416, valued at
$15k
Exercised 2,100 options to buy
@ $2.49, valued at
$5.2k
Exercised 1,500 options to buy
@ $2.49, valued at
$3.7k
Exercised 570 options to buy
@ $2.49, valued at
$1.4k
Exercised 2,800 options to buy
@ $0.9, valued at
$2.5k
|
|
| 02/19/2013 |
4
| Mackaness James H (CFO and COO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Sold 3,000 shares
@ $4.6109, valued at
$13.8k
Sold 3,000 shares
@ $4.4913, valued at
$13.5k
Exercised 3,000 options to buy
@ $2.49, valued at
$7.5k
Exercised 3,000 options to buy
@ $2.49, valued at
$7.5k
|
|
| 02/11/2013 |
4
| Mackaness James H (CFO & COO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Sold 3,000 shares
@ $4.4913, valued at
$13.5k
Sold 3,000 shares
@ $4.7293, valued at
$14.2k
Exercised 3,000 options to buy
@ $2.49, valued at
$7.5k
Exercised 3,000 options to buy
@ $2.49, valued at
$7.5k
|
|
| 12/17/2012 |
4
| Mackaness James H (CFO and COO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Granted 72,500 options to buy
@ $3.856, valued at
$279.6k
|
|
| 12/09/2011 |
4
| Mackaness James H (CFO) has filed a Form 4 on IRIDEX CORP|
Txns:
| Granted 50,000 options to buy
@ $3.6, valued at
$180k
|
|
| 05/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2008 |
4
| Mackaness James H (CFO) has filed a Form 4 on IRIDEX CORP |
|
|